Targeting alarmin release reverses Sjogren's syndrome phenotype by revitalizing Ca 2+ signalling
Clinical and Translational Medicine · 2023-04 · 13 (4)
DOI: 10.1002/ctm2.1228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 03.04.2023. Verfasst von Yuyang Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics, School of Dentistry, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Sjogren's Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Primary Sjogren's syndrome (pSS) is a systemic autoimmune disease that is embodied by the loss of salivary gland function and immune cell infiltration, but the mechanism(s) are still unknown. The aim of this study was to understand the mechanisms and identify key factors that leads to the development and progression of pSS.
Methods
Immunohistochemistry staining, FACS analysis and cytokine levels were used to detect immune cells infiltration and activation in salivary glands. RNA sequencing was performed to identify the molecular mechanisms involved in the development of pSS. The function assays include in vivo saliva collection along with calcium imaging and electrophysiology on isolated salivary gland cells in mice models of pSS. Western blotting, real‐time PCR, alarmin release, and immunohistochemistry was performed to identify the channels involved in salivary function in pSS.
Results
We provide evidence that loss of Ca 2+ signaling precedes a decrease in saliva secretion and/or immune cell infiltration in IL14α, a mouse model for pSS. We also showed that Ca 2+ homeostasis was mediated by transient receptor potential canonical‐1 (TRPC1) channels and inhibition of TRPC1, resulting in the loss of salivary acinar cells, which promoted alarmin release essential for immune cell infiltration/release of pro‐inflammatory cytokines. In addition, both IL14α and samples from human pSS patients showed a decrease in TRPC1 expression and increased acinar cell death. Finally, paquinimod treatment in IL14α restored Ca 2+ homeostasis that inhibited alarmin release thereby reverting the pSS phenotype.
Conclusions
These results indicate that loss of Ca 2+ signaling is one of the initial factors, which induces loss of salivary gland function along with immune infiltration that exaggerates pSS. Importantly, restoration of Ca 2+ signaling upon paquinimod treatment reversed the pSS phenotype thereby inhibiting the progressive development of pSS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontics, School of Dentistry, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
- Department of Developmental Dentistry, School of Dentistry, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
- Division of Allergy, Immunology, and Rheumatology, Department of Medicine, School of Medicine and Biomedical Sciences, State University of New York, Buffalo, New York, USA.
- Department of Oral and Maxillofacial Surgery, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
- Department of Rheumatology and Clinical Immunology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
- Department of Medicine, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
Förderung
- NIDCR NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Sun, Y., Nascimento Da Conceicao, V., Chauhan, A., Sukumaran, P., Chauhan, P., Ambrus, J. L., Vissink, A., Kroese, F. G. M., Muniswamy, M., Mishra, B. B., & Singh, B. B. (2023). Targeting alarmin release reverses Sjogren's syndrome phenotype by revitalizing Ca 2+ signalling. Clinical and Translational Medicine, 13(4). https://doi.org/10.1002/ctm2.1228
Vancouver
Sun Y, Nascimento Da Conceicao V, Chauhan A, Sukumaran P, Chauhan P, Ambrus JL, et al. Targeting alarmin release reverses Sjogren's syndrome phenotype by revitalizing Ca 2+ signalling. Clinical and Translational Medicine. 2023;13(4). doi:10.1002/ctm2.1228
BibTeX
@article{Sun2023,
author = {Sun, Yuyang and Nascimento Da Conceicao, Viviane and Chauhan, Arun and Sukumaran, Pramod and Chauhan, Pooja and Ambrus, Julian L and Vissink, Arjan and Kroese, Frans G M and Muniswamy, Madesh and Mishra, Bibhuti B and Singh, Brij B},
title = {Targeting alarmin release reverses Sjogren's syndrome phenotype by revitalizing Ca 2+ signalling},
journal = {Clinical and Translational Medicine},
year = {2023},
volume = {13},
number = {4},
doi = {10.1002/ctm2.1228}
}
EUVIMED